Rachel Kravitz
Principal Scientist - Research & Development Catalent
Dr. Rachel Kravitz is a Principal Scientist at Catalent Pharma Solutions as part of the Research & Development group. She works closely with the Cell Line Development and Molecular Biology departments. Rachel received her Ph.D. from U.C. Davis in Microbiology, with an emphasis on virology and immunology. She has over 20 years of industry experience and currently focuses on innovating cell line development platforms
Seminars
Thursday 17th September 2026
From Design to Delivery: Enabling Bispecific Antibodies at mAb-Like Timelines with GPEx® Lightning & an Integrated PD Toolbox
11:30 am
- GPEx Lightning’s tunability to drive correct chain pairing and minimize product-related impurities
- Streamlined downstream purification platform leveraging a rapid high-throughput resin screen
- Integrated analytical toolbox
